Prostate cancer · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Radium-223 monotherapy Variant #01 Partial | — | — | 28d | — | 14.0 mo | — | — | 1 |
Samarium-153 monotherapy Variant #01 Partial | — | — | — | — | — | — | — | — |
Lutetium Lu 177 vipivotide tetraxetan monotherapy Variant #01 Partial | — | — | 42d | — | 15.3 mo | — | — | 1 |
3 of 3 regimens shown